Source:http://linkedlifedata.com/resource/pubmed/id/12445236
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
2002-11-26
|
pubmed:abstractText |
The purpose of this study was to investigate the potential of combining cytosine deaminase/5-fluorocytosine (CD/5-FC) gene therapy and radiation therapy (either external beam radiation or radioimmunotherapy [RIT]), for the treatment of prostate cancer.
|
pubmed:language |
eng
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antimetabolites,
http://linkedlifedata.com/resource/pubmed/chemical/Cytosine Deaminase,
http://linkedlifedata.com/resource/pubmed/chemical/Flucytosine,
http://linkedlifedata.com/resource/pubmed/chemical/Fluorouracil,
http://linkedlifedata.com/resource/pubmed/chemical/Nucleoside Deaminases
|
pubmed:status |
MEDLINE
|
pubmed:author | |
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
567-76
|
pubmed:dateRevised |
2006-11-15
|
pubmed:articleTitle |
Potential benefits of combining cytosine deaminase/5-fluorocytosine gene therapy and irradiation for prostate cancer: experimental study.
|
pubmed:affiliation |
Departments of Urology and Nuclear Medicine, Kanazawa University School of Medicine, Kanazawa, Japan.
|